Cargando…
Pancreatic enzyme supplementation versus placebo for improvement of gastrointestinal symptoms in non-responsive celiac disease: A cross-over randomized controlled trial
BACKGROUND: Pancreatic Exocrine Insufficiency (PEI) is a possible cause of recurrent/persistent symptoms in celiac disease. Although pancreatic enzyme supplementation may be used to treat non-responsive celiac disease (NRCD) in clinical practice, clinical outcomes are variable and there is limited a...
Autores principales: | Yoosuf, Shakira, Barrett, Caitlin G., Papamichael, Konstantinos, Madoff, Sarah E., Kurada, Satya, Hansen, Joshua, Silvester, Jocelyn A., Therrien, Amelie, Singh, Prashant, Dennis, Melinda, Leffler, Daniel A., Kelly, Ciaran P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845937/ https://www.ncbi.nlm.nih.gov/pubmed/36687454 http://dx.doi.org/10.3389/fmed.2022.1001879 |
Ejemplares similares
-
Society for the Study of Celiac Disease position statement on gaps and opportunities in coeliac disease
por: Pinto-Sanchez, M. Ines, et al.
Publicado: (2021) -
Non-responsive celiac disease in children on a gluten free diet
por: Veeraraghavan, Gopal, et al.
Publicado: (2021) -
Understanding celiac disease monitoring patterns and outcomes after diagnosis: A multinational, retrospective chart review study
por: Lundin, Knut EA, et al.
Publicado: (2021) -
Evolving Therapy for Celiac Disease
por: Yoosuf, Shakira, et al.
Publicado: (2019) -
Recent Advances in Celiac Disease from TTG to Gluten in Pee
por: Silvester, J A, et al.
Publicado: (2015)